Use access key #2 to skip to page content.
$12.30 -1.38 (-10.09%)
10/10/2008 4:00 PM

Amylin Pharmaceuticals, Inc. (AMLN)

CAPS Rating:
**

A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.

View All Commentary (AMLN)

Recs

0

Avatar crimfunk (< 20) Submitted: 6/13/08 2:38 PM : Underperform Start Price: $26.69 AMLN Score: -11.07

bear

Report this Post Replies: 0 | Reply

Featured Broker Partners